RA CAPITAL MANAGEMENT, L.P. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
RA CAPITAL MANAGEMENT, L.P. has filed 1,709 SEC EDGAR filings since 14 Dec 2005

SEC filing history

Showing 726-750 of 1,000 matching filings.

Per page
25
Current page
30
4 File 001-39247

OWNERSHIP DOCUMENT

Filing date
24 Oct 2022
Reporting date
20 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
21 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39122

OWNERSHIP DOCUMENT

Filing date
20 Oct 2022
Reporting date
18 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39247

OWNERSHIP DOCUMENT

Filing date
19 Oct 2022
Reporting date
17 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
19 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-40794

OWNERSHIP DOCUMENT

Filing date
19 Oct 2022
Reporting date
17 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-39247

OWNERSHIP DOCUMENT

Filing date
19 Oct 2022
Reporting date
17 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
17 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
17 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
14 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-39333

OWNERSHIP DOCUMENT

Filing date
14 Oct 2022
Reporting date
14 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
13 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
04 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
03 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A

SC 13G/A

Filing date
27 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
26 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
26 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
26 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
16 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
06 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
06 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

SC 13D/A

Filing date
02 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A

POINT BIOPHARMA GLOBAL INC.

Filing date
29 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-38978

OWNERSHIP DOCUMENT

Filing date
26 Aug 2022
Reporting date
16 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

FULCRUM THERAPEUTICS, INC.

Filing date
26 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .